Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib-Reference-Cited by-同舟云学术

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Published:2011-03-21 Issue:7 Volume:103 Page:553-561
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Gambacorti-Passerini Carlo,Antolini Laura,Mahon François-Xavier,Guilhot Francois,Deininger Michael,Fava Carmen,Nagler Arnon,Della Casa Chiara Maria,Morra Enrica,Abruzzese Elisabetta,D’Emilio Anna,Stagno Fabio,le Coutre Philipp,Hurtado-Monroy Rafael,Santini Valeria,Martino Bruno,Pane Fabrizio,Piccin Andrea,Giraldo Pilar,Assouline Sarit,Durosinmi Muheez A.,Leeksma Onno,Pogliani Enrico Maria,Puttini Miriam,Jang Eunjung,Reiffers Josy,Valsecchi Maria Grazia,Kim Dong-Wook

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/103/7/553/17311698/djr060.pdf

Reference27 articles.

1. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med.,2001

2. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;N Engl J Med.,2002

3. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O’Brien;N Engl J Med.,2003

4. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med.,2006

5. Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment;Hochhaus;Blood.,2008

Cited by 351 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global Trial Representation and Availability of Tyrosine Kinase Inhibitors for Treatment of Chronic Myeloid Leukemia;Cancers;2024-08-14

2. BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph+ leukemias?;Leukemia;2024-08-04

3. Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy;Frontiers in Oncology;2024-07-29

4. Imatinib Mesylate Causes Potential Cardiac Dysfunction in Patients With Chronic Myeloid Leukemia: the Results of a Case–control Study;Indian Journal of Hematology and Blood Transfusion;2024-07-08

5. Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1;Leukemia;2024-05-15